AlphaCrest Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,755
| Closed | -$244K | – | 1323 |
|
|
2021
Q4 | $244K | Buy |
+26,755
| New | +$244K | 0.01% | 1300 |
|
|
2021
Q2 | – | Sell |
-19,123
| Closed | -$310K | – | 1280 |
|
|
2021
Q1 | $310K | Buy |
19,123
+8,886
| +87% | +$144K | 0.02% | 1012 |
|
|
2020
Q4 | $217K | Buy |
+10,237
| New | +$217K | 0.02% | 1050 |
|
|
2020
Q3 | – | Sell |
-12,494
| Closed | -$184K | – | 1140 |
|
|
2020
Q2 | $184K | Sell |
12,494
-20,387
| -62% | -$300K | 0.03% | 852 |
|
|
2020
Q1 | $386K | Buy |
32,881
+18,909
| +135% | +$222K | 0.05% | 683 |
|
|
2019
Q4 | $328K | Buy |
+13,972
| New | +$328K | 0.03% | 1013 |
|